Published in Parkinsonism Relat Disord on June 01, 2004
Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol (2009) 2.29
Did My Brain Implant Make Me Do It? Questions Raised by DBS Regarding Psychological Continuity, Responsibility for Action and Mental Competence. Neuroethics (2010) 1.13
Impulse control disorders following deep brain stimulation of the subthalamic nucleus in Parkinson's disease: clinical aspects. Parkinsons Dis (2011) 0.96
Influence of bilateral Stn-stimulation on psychiatric symptoms and psychosocial functioning in patients with Parkinson's disease. J Neural Transm (Vienna) (2005) 0.89
Long-term effects of STN DBS on mood: psychosocial profiles remain stable in a 3-year follow-up. BMC Neurol (2008) 0.86
Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. Mov Disord (2015) 0.82
Impulsive and compulsive behaviors in Parkinson's disease. Front Aging Neurosci (2014) 0.82
The Subthalamic Nucleus, Limbic Function, and Impulse Control. Neuropsychol Rev (2015) 0.81
Do patient's get angrier following STN, GPi, and thalamic deep brain stimulation. Neuroimage (2010) 0.78
Imaging impulsivity in Parkinson's disease and the contribution of the subthalamic nucleus. Parkinsons Dis (2011) 0.78
Towards new human rights in the age of neuroscience and neurotechnology. Life Sci Soc Policy (2017) 0.75
Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical Correlates. Stereotact Funct Neurosurg (2016) 0.75
Autonomy in Depressive Patients Undergoing DBS-Treatment: Informed Consent, Freedom of Will and DBS' Potential to Restore It. Front Integr Neurosci (2017) 0.75
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler (2006) 2.83
Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial. Neurology (2010) 2.14
Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology (2011) 2.10
Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60
Ganglioside therapy and Guillain-Barré syndrome. A historical cohort study in Ferrara, Italy, fails to demonstrate an association. Neuroepidemiology (1991) 1.60
The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A. Clin Auton Res (2002) 1.51
Improving morning care routines of nursing home residents with dementia. J Am Geriatr Soc (1999) 1.48
Five-year follow-up of 10 patients treated with globus pallidus internus deep brain stimulation for segmental or multisegmental dystonia. Stereotact Funct Neurosurg (2012) 1.48
Clinical outcome of deep brain stimulation for dystonia: constant-current or constant-voltage stimulation? A non-randomized study. Eur J Neurol (2014) 1.48
Incidence of the Guillain-Barré syndrome in Ferrara, northern Italy, 1981-1987. Neuroepidemiology (1991) 1.44
Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis. Neurology (2010) 1.44
Restless legs syndrome and pregnancy. Neurology (2004) 1.40
The history of the tic douloureux: autopathograph of an Italian lawyer who suffered from trigeminal neuralgia from 1803 to 1824. J Hist Neurosci (1996) 1.39
Neurophysiological study of Horner's syndrome. Acta Neurol Scand (1991) 1.39
European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol (2000) 1.14
Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol (2001) 1.14
Studies on epidemiological, clinical, and etiological aspects of ALS disease in Sardinia, Southern Italy. Acta Neurol Scand (1977) 1.11
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol (2011) 1.11
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler (2011) 1.11
The risk of Parkinson disease in Mediterranean people. Neurology (1980) 1.11
Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans. Neurosci Lett (1998) 1.08
The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord (1997) 1.05
Is Ross syndrome a dysautonomic disorder only? An electrophysiologic and histologic study. Clin Neurophysiol (2003) 1.04
Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology (2011) 1.04
Myasthenia gravis: a changing pattern of incidence. J Neurol (2010) 1.04
A descriptive study of epilepsy in the district of Copparo, Italy, 1964-1978. Epilepsia (1983) 1.03
Entrapment of the suprascapular nerve at the spinoglenoid notch. Ann Neurol (1982) 1.00
Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis. Mult Scler (2009) 0.99
Vibrational, 1H-NMR spectroscopic, and thermal characterization of gladiolus root exudates in relation to Fusarium oxysporum f. sp. gladioli resistance. Biopolymers (2002) 0.98
The increasing incidence and prevalence of MS in a Sardinian province. Neurology (2000) 0.97
Motor neuron disease in the province of Ferrara, Italy, in 1964-1982. Neurology (1988) 0.97
Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology (1994) 0.96
Systemic lupus erythematosus presenting with neurological disorders. J Neurol (1992) 0.96
Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol (1991) 0.96
The relationship between cerebral vascular disease and parkinsonism: The VADO study. Parkinsonism Relat Disord (2012) 0.96
Botulinum neurotoxins: mechanism of action and therapeutic applications. Mol Med Today (1996) 0.95
Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human. Neurosci Lett (1997) 0.94
Metabolic findings on 3T 1H-MR spectroscopy in peritumoral brain edema. AJNR Am J Neuroradiol (2007) 0.94
Prevalence of Parkinson's disease in the Republic of San Marino. Neurology (1987) 0.94
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler (2006) 0.93
Multiple sclerosis in the province of Ferrara : evidence for an increasing trend. J Neurol (2007) 0.92
Three years of experience: the Italian registry and safety data update. Neurol Sci (2011) 0.92
Cluster-beam deposition and in situ characterization of carbyne-rich carbon films. Phys Rev Lett (2002) 0.92
Management of parotid sialocele with botulinum toxin. Laryngoscope (1999) 0.92
Molecular characterization of human healthy and neoplastic cerebral and renal tissues by in vitro (1)H NMR spectroscopy (review). Int J Mol Med (2002) 0.91
Monday preference in onset of ischemic stroke. Am J Med (2001) 0.91
Oxidative stress, antioxidants and neurodegenerative diseases. Curr Pharm Des (2005) 0.91
Botulism-like syndrome after botulinum toxin type A injections for focal hyperhidrosis. Br J Dermatol (2002) 0.91
Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy. Neuroepidemiology (2001) 0.91
Advanced laboratory techniques for diagnosing Toxoplasma gondii encephalitis in AIDS patients: significance of intrathecal production and comparison with PCR and ECL-western blotting. J Neuroimmunol (1998) 0.91
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients. Mult Scler (1998) 0.90
Early predictors of intractability in childhood epilepsy: a community-based case-control study in Copparo, Italy. Acta Neurol Scand (1999) 0.90
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases. Neurol Sci (2004) 0.90
Intracranial gliomas in Ferrara, Italy, 1976 to 1991. Acta Neurol Scand (1994) 0.88
Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Mult Scler (2004) 0.88
Cardiac and humoral changes induced by recreational scuba diving. Undersea Hyperb Med (1999) 0.88
Conjugal amyotrophic lateral sclerosis. Ann Neurol (1983) 0.87
Influence of cumulenic chains on the vibrational and electronic properties of s p-s p2 amorphous carbon. Phys Rev Lett (2007) 0.87
Multiple sclerosis: infectious hypothesis. Neurol Sci (2001) 0.87
Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol (Napoli) (1994) 0.86
Potentiometric determination of carbonic anhydrase activity in rabbit carotid bodies: comparison among normoxic, hyperoxic and hypoxic animals. Neurosci Lett (1994) 0.86
Multiple sclerosis in Italy. A reappraisal of incidence and prevalence in Ferrara. Arch Neurol (1996) 0.85
Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med (1995) 0.85
Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurol Sci (2013) 0.85
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis. Mult Scler (2009) 0.84
Multiple sclerosis in southern Europe. A prevalence study in the sociosanitary district of Copparo, northern Italy. Acta Neurol Scand (1980) 0.84
Epidemiology of multiple sclerosis in Italy and in southern Europe. Acta Neurol Scand Suppl (1995) 0.84
Treatment of Frey syndrome with botulinum toxin type F. Arch Otolaryngol Head Neck Surg (2001) 0.84
Pattern electroretinogram in multiple sclerosis. J Neurol Neurosurg Psychiatry (1984) 0.84
Clinical use of non-A botulinum toxins: botulinum toxin type B. Neurotox Res (2006) 0.84
Post-activation depression in various group I spinal pathways in humans. Exp Brain Res (2005) 0.84
Incidence of childhood and adolescence epilepsy: a community-based prospective study in the province of Ferrara and in Copparo, Italy, 1996-2005. Eur J Neurol (2011) 0.83
Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy. Acta Neurol Scand (1994) 0.83
Neurological involvement in primary Sjögren's syndrome: clinical and instrumental evaluation in a cohort of Italian patients. Clin Rheumatol (1999) 0.83
Static vestibulospinal influences in relation to different body tilts in man. Exp Neurol (1983) 0.83
Clinical use of non-A botulinum toxins: botulinum toxin type C and botulinum toxin type F. Neurotox Res (2006) 0.83
A prospective study on the predictive value of CSF oligoclonal bands and MRI in acute isolated neurological syndromes for subsequent progression to multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.83
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients. J Neural Transm (Vienna) (2014) 0.83